Webcasts & Presentations

Neurocrine’s management team participates in industry conferences providing presentations on company updates and progress on research and development activities. The company conducts webcasts and conference calls for these conferences and provides financial highlights and company news updates during regularly scheduled conference calls. For questions or information on current or future webcasts and conference calls contact ir@neurocrine.com. Webcast links and presentations will remain on this website for approximately 30 days or unless earlier replaced.

Neurocrine Biosciences Presented at Bank of America Securities 2020 Napa Biopharma Conference
Kevin Gorman, Chief Executive Officer, and Kyle Gano, Chief Business Development and Strategy Officer, presented at the conference
June 22nd, 2020 2:00 p.m. PT / 5:00 p.m. ET
Webcast Link

Neurocrine Biosciences and Takeda Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders
Neurocrine Biosciences hosted a conference call to discuss the collaboration
June 16th, 2020 8:00 a.m. ET
Webcast Link

Neurocrine Biosciences Presented at Goldman Sachs 41st Annual Global Healthcare Conference Webcast
Kevin Gorman, Chief Executive Officer, and Eiry Roberts, Chief Medical Officer, presented at the conference
June 11th, 2020 9:40 a.m. ET
Webcast Link

Neurocrine Biosciences Reports Positive Phase II Data for Crinecerfont in Adults with Congenital Adrenal Hyperplasia at ENDO Online 2020
Richard Auchus, M.D., Ph.D., the study’s lead investigator and Professor of Internal Medicine, Division of Metabolism, Endocrinology & Diabetes at Michigan Medicine
June 8, 2020 at ENDO Online 2020
Presentation Link

Neurocrine Biosciences Presented at Jefferies Virtual Healthcare Conference
Kevin Gorman, Chief Executive Officer, presented at the conference
June 2nd, 2020 11:00 a.m. ET
Webcast Link